PDL BioPharma (United States)

PDL BioPharma (United States)

PDL BioPharma is a publicly traded American holding company that since 2008 manages patents and other intellectual property that had been generated by the company. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PDL BioPharma (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

47%


Total
Publications

251


Total Open
Publications

118


Total
Citations

25K


Open Access
Percentage

47%


Total
Publications

251


Total Open
Publications

118


Total
Citations

25K

Wikipedia

Website

download

Breakdown

18% 13% 16% 53%

Publisher Open

18%

Both

13%

Other Platform Open

16%

Closed

53%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

8%OA Journal

OA Journal 8%

6

Hybrid 27%

21

No Guarantees 65%

50

Other Platform Open

Domain 85%

63

Institution 12%

9

Public 11%

8

Other Internet 9%

7

Preprint 7%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
65
Europe PMC
Domain
49
DOI
Other Internet
10
Figshare
Public
7
Semantic Scholar
Public
5
Kanazawa University - Kanazawa University Repository for Academic Resources (DSpace)
Institution
4
bioRxiv
Preprint
4
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
California Institute of Technology - CaltechAUTHORS
Institution
2
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
1
1 / 3

Data updated 7 April 2025

Share

Share

Share